Clinical Trial Update: A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial update for MSTT1041A in uncontrolled severe asthma completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MSTT1041A

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2022-12-28